Array BioPharma Reports Financial Results For The First Quarter Of Fiscal 2017

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. RNG
2. WDC
3. DECK
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. FIX

Go back to Array BioPharma Reports Financial Results For The First Quarter Of Fiscal 2017

Array Biopharma (ARRY) Misses Q1 EPS by 4c, Sales Beat

November 1, 2016 8:02 AM EDT

Array Biopharma (NASDAQ: ARRY) reported Q1 EPS of ($0.20), $0.04 worse than the analyst estimate of ($0.16). Revenue for the quarter came in at $39.3 million versus the consensus estimate of $32.47 million.

"We were pleased to report that COLUMBUS met its primary endpoint and demonstrated a... More